| scholarly article | Q13442814 |
| P2093 | author name string | Victor M Montori | |
| Viet-Thi Tran | |||
| Jorge Correale | |||
| Sandra Vanotti | |||
| María Célica Ysrraelit | |||
| Fernando Vazquez Peña | |||
| Sergio Adrián Terrasa | |||
| Marcela Paula Fiol | |||
| P2860 | cites work | Patient capacity for self-care in the medical record of patients with chronic conditions: a mixed-methods retrospective study | Q57044035 |
| Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis | Q64029447 | ||
| The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus | Q69772148 | ||
| Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease | Q80090456 | ||
| Associations Between Treatment Satisfaction, Medication Beliefs, and Adherence to Disease-Modifying Therapies in Patients with Multiple Sclerosis | Q90650024 | ||
| Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 | ||
| Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria | Q24605493 | ||
| Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective | Q27026313 | ||
| The hospital anxiety and depression scale | Q27860968 | ||
| Medication-related burden and patients' lived experience with medicine: a systematic review and metasynthesis of qualitative studies | Q28075373 | ||
| Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform | Q28655693 | ||
| Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance | Q29615569 | ||
| Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden. | Q30276056 | ||
| Factors that lessen the burden of treatment in complex patients with chronic conditions: a qualitative study | Q30574599 | ||
| Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis | Q33605353 | ||
| New insights into the burden and costs of multiple sclerosis in Europe | Q33811618 | ||
| Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness | Q33840905 | ||
| Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ). | Q34160752 | ||
| Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions | Q34326913 | ||
| Treatment Burden and Treatment Fatigue as Barriers to Health. | Q35734289 | ||
| The burden of multiple sclerosis 2015: Methods of data collection, assessment and analysis of costs, quality of life and symptoms | Q36413166 | ||
| Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) | Q36538213 | ||
| Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials | Q37052208 | ||
| Burden of treatment for chronic illness: a concept analysis and review of the literature. | Q37333252 | ||
| Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations | Q38735869 | ||
| Adherence to Disease-Modifying Therapies for Multiple Sclerosis | Q39018651 | ||
| Concurrent and predictive validity of a self-reported measure of medication adherence | Q39512844 | ||
| Development of a multiple sclerosis functional composite as a clinical trial outcome measure | Q40810823 | ||
| A checklist for evaluating the usefulness of rating scales | Q40894273 | ||
| Measuring the burden of treatment for chronic disease: implications of a scoping review of the literature | Q41172036 | ||
| Therapy Optimization in Multiple Sclerosis: a cohort study of therapy adherence and risk of relapse | Q41196946 | ||
| A health-related quality of life measure for multiple sclerosis | Q46724695 | ||
| A conceptual model of treatment burden and patient capacity in stroke. | Q47349041 | ||
| Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists | Q47551268 | ||
| Development and validation of an instrument for measuring the burden of medicine on functioning and well-being: the Medication-Related Burden Quality of Life (MRB-QoL) tool. | Q47560188 | ||
| Light therapy for multiple sclerosis-associated fatigue: Study protocol for a randomized controlled trial. | Q47687936 | ||
| Assessing the Burden of Treatment. | Q52579850 | ||
| The payer's perspective: What is the burden of MS and how should the patient's perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment? | Q52985191 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 209 | |
| P577 | publication date | 2019-08-27 | |
| P1433 | published in | BMC Neurology | Q15763734 |
| P1476 | title | Adaptation and validation of a Spanish version of the treatment burden questionnaire in patients with multiple sclerosis | |
| P478 | volume | 19 |
Search more.